诊断性乳腺检查中数字二维乳腺X线摄影与断层合成乳腺X线摄影的性能指标比较
该研究连续纳入2008年8月至2011年2月的数字二维乳腺X线摄影(DM组)和2013年1月至2015年7月的数字乳腺断层合成(DM/DBT组)诊断性检查,收集365天内的活检和手术病理结果。调整临床协变量后,两组癌症检出率无显著差异(DM/DBT组38.2/1000 vs DM组31.3/1000,p=0.14),但DM/DBT组浸润性癌比例更高(83.7% vs 72.3%,p<0.01),异常判读率更低,PPV2、PPV3和特异度更高。结论认为将DBT完全整合到诊断性检查中与诊断性能改善相关。
要点
- DM/DBT组异常判读率低于DM组(p<0.01),PPV2、PPV3和特异度均高于DM组。
- DM/DBT组癌症检出率与DM组无显著差异(38.2/1000 vs 31.3/1000,p=0.14)。
- DM/DBT组浸润性癌占83.7%(731/873),高于DM组的72.3%(518/716),p<0.01。
核心结论
- 将DBT完全整合到诊断性检查中与诊断性能改善相关,DBT使用增加可能改善患者结局并导致DM既定基准的转变。
研究设计与样本
- 连续诊断性检查的回顾性比较,DM组22,883例(2008年8月至2011年2月),DM/DBT组22,824例(2013年1月至2015年7月),收集乳腺X线摄影后365天内的空芯针活检和手术病理结果,采用多变量逻辑回归模型调整临床协变量后比较性能指标。
关键影像表现/征象
- DM/DBT组癌症检出率为38.2/1000例检查,DM组为31.3/1000例检查,两组差异无统计学显著(p=0.14)。
- DM/DBT组浸润性癌占83.7%(731/873),DM组占72.3%(518/716),DM/DBT组浸润性癌比例更高(p<0.01)。
诊断标准与关键数值
- DM/DBT组异常判读率低于DM组(p<0.01)。
- DM/DBT组PPV2、PPV3和特异度均高于DM组(所有p=0.01或p<0.01)。
临床应用与阅片要点
- 在诊断性乳腺检查中,DBT整合后异常判读率更低、PPV2、PPV3和特异度更高,而癌症检出率与DM相似。
- DBT整合后浸润性癌占检出癌症的比例更高(83.7% vs 72.3%),提示阅片时需结合此分布变化理解检出癌的构成。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare performance metrics between digital 2D mammography (DM) and digital breast tomosynthesis (DBT) in the diagnostic setting.
METHODS: Consecutive diagnostic examinations from August 2008 to February 2011 (DM group) and from January 2013 to July 2015 (DM/DBT group) were reviewed. Core biopsy and surgical pathology results within 365 days after the mammogram were collected. Performance metrics, including cancer detection rate (CDR), abnormal interpretation rate (AIR), positive predictive value (PPV) 2, PPV3, sensitivity, and specificity were calculated. Multivariable logistic regression models were fit to compare performance metrics in the DM and DM/DBT groups while adjusting for clinical covariates.
RESULTS: A total of 22,883 mammograms were performed before DBT integration (DM group), and 22,824 mammograms were performed after complete DBT integration (DM/DBT group). After adjusting for multiple variables, the CDR was similar in both groups (38.2 per 1,000 examinations in the DM/DBT group versus 31.3 per 1,000 examinations in the DM group, p = 0.14); however, a higher proportion of cancers were invasive rather than in situ in the DM/DBT group [83.7% (731/873) versus 72.3% (518/716), p < 0.01]. The AIR was lower in the DM/DBT group (p < 0.01), and PPV2, PPV3, and specificity were higher in the DM/DBT group (all p = 0.01 or p < 0.01).
CONCLUSIONS: Complete integration of DBT into the diagnostic setting is associated with improved diagnostic performance. Increased utilization of DBT may thus result in better patient outcomes and lead to a shift in the benchmarks that have been established for DM.
KEY POINTS: • Integration of tomosynthesis into the diagnostic setting is associated with improved performance. • A higher proportion of cancers are invasive rather than in situ with digital breast tomosynthesis. • Increased utilization of tomosynthesis may lead to a shift in established benchmarks.
引用
- Bahl M, Mercaldo S, Vijapura CA, et al. Comparison of performance metrics with digital 2D versus tomosynthesis mammography in the diagnostic setting. Eur Radiol. 2018. PMID: 29967957. doi:10.1007/s00330-018-5596-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。